Please login to the form below

Not currently logged in
Email:
Password:

Britannia promotes Robert Wood

He takes up new marketing director role

Britannia_Robert_WoodBritannia Pharmaceuticals has promoted Robert Wood to marketing director, for international markets.

Wood was previously director partners, EMEA at Britannia and has 15 years experience in the life science and pharmaceutical industries.

Prior to joining Britannia, which is part of Stada, in early 2011, his roles included business unit director, pharmaceuticals at International SOS and vice president of business development at Optasia Medical.

Britannia Pharmaceuticals has been working in Parkinson's disease for over thirty years and its APO-go product range is licensed in almost 40 countries.

Wood said: “I am delighted to be continuing to work with Britannia Pharmaceuticals in this new global role, particularly at this incredibly interesting time for the APO-go therapy.

“The initiation of clinical trials to increase the evidence base for both motor and non-motor effects of APO-go in Parkinson's disease and the development of new delivery devices, mean APO-go will provide an excellent treatment option for many more people with Parkinson's.”

3rd May 2013

From: Marketing

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Thrive Agency

We are a specialist health communication agency creating powerful and trusted content. If you’re looking for a partner to help...

Latest intelligence

Main image1
Global leaders in digital channels
Exploring why UK field teams are global leaders in digital channels is key to better understanding the changes in omnichannel engagement...
Kate Shaw reflects on Innovative Trials' first US office openings
On Thanksgiving, Kate Shaw, Founder and CEO of Innovative Trials, reflects on the company first US office opening...
Meeting1
Reimagining strategy development for a hybrid workforce
By Janice MacLennan...